Autres langues AbbVie Inc. NEO Exchange

Actions

Cours en clôture NEO Exchange Autres places de cotation 00:00:00 02/07/2024			Varia. 5j.	Varia. 1 janv.
24,2 ^CAD	-3,20%		-2,89%	+6,75%

01/07	Merus nomme un nouveau directeur médical	MT
01/07	AbbVie : le nouveau directeur général prend ses fonctions	CF

AbbVie to Host Second-Quarter 2024 Earnings Conference Call	02/07
Merus Names New Chief Medical Officer	01/07
AbbVie : le nouveau directeur général prend ses fonctions	01/07
AbbVie Says Robert Michael Assumes CEO Role	01/07
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer	01/07
AbbVie Announces Board Changes	01/07
AbbVie Inc.(NYSE:ABBV) added to Russell 1000 Value Index	01/07
AbbVie Inc.(NYSE:ABBV) added to Russell 3000E Value Index	01/07
AbbVie - Introducing Alle Payment Plans, Powered by Cherry	28/06
Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	28/06
AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	28/06
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28/06
AbbVie Receives Positive CHMP Opinion for Epcoritamab for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28/06
Health Care Stocks Fall With Broad Market -- Health Care Roundup	27/06
Sector Update: Health Care Stocks Slipping Late Afternoon	27/06
Sector Update: Health Care Stocks Decline in Afternoon Trading	27/06
AbbVie : acquisition de Celsius pour 250 millions de dollars	27/06
AbbVie Buys Celsius Therapeutics for $250 Million	27/06
AbbVie Buys Celsius Therapeutics for $250 million	27/06
AbbVie Buys Celsius Therapeutics for $250 million	27/06

Aucun résultat pour cette recherche